Will India’s Covishield export halt amid coronavirus surge hurt its vaccine diplomacy?

• Officials have defended the decision to ‘calibrate’ Oxford/AstraZeneca vaccine exports made by the Serum Institute of India as the country experiences a second wave
• But while production is being ramped up, the temporary halt in deliveries could affect Prime Minister Narendra Modi’s soft power efforts